Certara Newsroom

Certara Analyst Ratings

BenzingaJul 10 10:24 ET

Certara (CERT) Gets a Hold From Barclays

TipRanksJul 10 04:48 ET

Market Perform Rating for Certara Amid Strategic Acquisition and Mixed Financial Outlook

TipRanksJul 10 00:27 ET

Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating

MT NewswiresJun 28 11:55 ET

Certara Analyst Ratings

BenzingaJun 28 11:45 ET

Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL)

TipRanksMay 10 01:55 ET

Certara Analyst Maintains Hold Rating Amid Mixed Financial Performance and Strategic Developments

TipRanksMay 10 01:45 ET

Certara (CERT) Gets a Hold From Barclays

TipRanksMay 8 06:11 ET

Certara (CERT) Gets a Hold From JMP Securities

TipRanksMay 8 01:50 ET

R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space

Seeking AlphaApr 10 12:58 ET

Certara Analyst Ratings

BenzingaApr 10 04:37 ET

Barclays Remains a Hold on Certara (CERT)

TipRanksApr 10 03:06 ET

Certara Analyst Ratings

BenzingaApr 4 04:54 ET

Certara Analyst Ratings

BenzingaMar 1 07:21 ET

Barclays Issues a Hold Rating on Certara (CERT)

TipRanksMar 1 02:55 ET

Leerink Partners Initiates Coverage On Certara With Market Perform Rating, Announces Price Target of $19

BenzingaFeb 26 08:36 ET

Certara Analyst Ratings

BenzingaFeb 26 08:35 ET

Certara Analyst Ratings

BenzingaJan 25 09:42 ET

UBS Initiates Coverage On Certara With Neutral Rating, Announces Price Target of $17

BenzingaDec 7, 2023 06:09 ET

Certara Analyst Ratings

BenzingaDec 7, 2023 06:08 ET